Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC GSK256066 Trifluoroacetate | 1415560-64-3 | 99.8% | C29H27F3N4O7S | 50 MG
Supplier: Medchemexpress LLC HY7006950MG
GSK256066 Trifluoroacetate is a selective and high-affinity phosphodiesterase 4 (PDE) inhibitor, with an IC50 of 3.2 pM for PDE4B. It is developed for the research of chronic obstructive pulmonary disease.
- Selective and high-affinity phosphodiesterase 4 (PDE) inhibitor
- IC50 of 3.2 pM for PDE4B
- Developed for the research of chronic obstructive pulmonary disease
- Exceptionally high-affinity inhibitor of PDE4 designed for inhaled administration
- Highly selective for PDE4
- Inhibits PDE4 isoforms A-D with equal affinity
- Inhibits tumor necrosis factor α production by LPS-stimulated human peripheral blood monocytes with IC50 of 0.01 nM
- Inhibits eosinophil number in BAL in LPS- and OVA-induced acute pulmonary inflammation rat models
- Inhibits LPS-induced pulmonary neutrophilia
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?